<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33827951</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>24</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e00304-21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00304-21</ELocationID><Abstract><AbstractText>During viral infection, the dynamic virus-host relationship is constantly in play. Many cellular proteins, such as RNA-binding proteins (RBPs), have been shown to mediate antiviral responses during viral infection. Here, we report that the RBP FUS/TLS (fused in sarcoma/translocated in liposarcoma) acts as a host-restricting factor against infection with coxsackievirus B3 (CVB3). Mechanistically, we found that deletion of FUS leads to increased viral RNA transcription and enhanced internal ribosome entry site (IRES)-driven translation, with no apparent impact on viral RNA stability. We further demonstrated that FUS physically interacts with the viral genome, which may contribute to direct inhibition of viral RNA transcription/translation. Moreover, we identified a novel function for FUS in regulating host innate immune response. We show that in the absence of FUS, gene expression of type I interferons and proinflammatory cytokines elicited by viral or bacterial infection is significantly impaired. Emerging evidence suggests a role for stress granules (SGs) in antiviral innate immunity. We further reveal that knockout of FUS abolishes the ability to form SGs upon CVB3 infection or poly(I&#xb7;C) treatment. Finally, we show that, to avoid FUS-mediated antiviral response and innate immunity, CVB3 infection results in cytoplasmic mislocalization and cleavage of FUS through the enzymatic activity of viral proteases. Together, our findings in this study identify FUS as a novel host antiviral factor which restricts CVB3 replication through direct inhibition of viral RNA transcription and protein translation and through regulation of host antiviral innate immunity.<b>IMPORTANCE</b> Enteroviruses are common human pathogens, including those that cause myocarditis (coxsackievirus B3 [CVB3]), poliomyelitis (poliovirus), and hand, foot, and mouth disease (enterovirus 71). Understanding the virus-host interaction is crucial for developing means of treating and preventing diseases caused by these pathogens. In this study, we explored the interplay between the host RNA-binding protein FUS/TLS and CVB3 and found that FUS/TLS restricts CVB3 replication through direct inhibition of viral RNA transcription/translation and through regulation of cellular antiviral innate immunity. To impede the antiviral role of FUS, CVB3 targets FUS for mislocalization and cleavage. Findings from this study provide novel insights into interactions between CVB3 and FUS, which may lead to novel therapeutic interventions against enterovirus-induced diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Xue et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Yuan Chao</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Chen Seng</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamud</LastName><ForeName>Yasir</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fung</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Huitao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahreyni</LastName><ForeName>Amirhossein</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jingchun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7708-7840</Identifier><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada Honglin.Luo@hli.ubc.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PJT-173318</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>PJT-159546</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599551">FUS protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067556">Internal Ribosome Entry Sites</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.29</RegistryNumber><NameOfSubstance UI="C057400">picornain 2A, Picornavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>O84C90HH2L</RegistryNumber><NameOfSubstance UI="D011070">Poly I-C</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003594" MajorTopicYN="N">Cytoplasmic Granules</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055786" MajorTopicYN="N">Gene Knockout Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067556" MajorTopicYN="N">Internal Ribosome Entry Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011070" MajorTopicYN="N">Poly I-C</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA binding proteins</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">host response</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>8</Day><Hour>5</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33827951</ArticleId><ArticleId IdType="pmc">PMC8316056</ArticleId><ArticleId IdType="doi">10.1128/JVI.00304-21</ArticleId><ArticleId IdType="pii">JVI.00304-21</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garmaroudi FS, Marchant D, Hendry R, Luo H, Yang D, Ye X, Shi J, McManus BM. 2015. Coxsackievirus B3 replication and pathogenesis. Future Microbiol 10:629&#x2013;653. 10.2217/fmb.15.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Meylan E, Tschopp J, Karin M. 2006. Intracellular pattern recognition receptors in the host response. Nature 442:39&#x2013;44. 10.1038/nature04946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04946</ArticleId><ArticleId IdType="pubmed">16823444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J, Si X, Angeles A, Zhang J, Shi J, Fung G, Jagdeo J, Wang T, Zhong Z, Jan E, Luo H. 2013. Cytoplasmic redistribution and cleavage of AUF1 during coxsackievirus infection enhance the stability of its viral genome. FASEB J 27:2777&#x2013;2787. 10.1096/fj.12-226498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.12-226498</ArticleId><ArticleId IdType="pubmed">23572232</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung G, Shi J, Deng H, Hou J, Wang C, Hong A, Zhang J, Jia W, Luo H. 2015. Cytoplasmic translocation, aggregation, and cleavage of TDP-43 by enteroviral proteases modulate viral pathogenesis. Cell Death Differ 22:2087&#x2013;2097. 10.1038/cdd.2015.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.58</ArticleId><ArticleId IdType="pmc">PMC4816113</ArticleId><ArticleId IdType="pubmed">25976304</ArticleId></ArticleIdList></Reference><Reference><Citation>Masaki K, Sonobe Y, Ghadge G, Pytel P, Roos RP. 2019. TDP-43 proteinopathy in Theiler&#x2019;s murine encephalomyelitis virus infection. PLoS Pathog 15:e1007574. 10.1371/journal.ppat.1007574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007574</ArticleId><ArticleId IdType="pmc">PMC6390522</ArticleId><ArticleId IdType="pubmed">30742696</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue YC, Ruller CM, Fung G, Mohamud Y, Deng H, Liu H, Zhang J, Feuer R, Luo H. 2018. Enteroviral infection leads to transactive response DNA-binding protein 43 pathology in vivo. Am J Pathol 188:2853&#x2013;2862. 10.1016/j.ajpath.2018.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2018.08.013</ArticleId><ArticleId IdType="pubmed">30273599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullmer W, Semler BL. 2018. Direct and indirect effects on viral translation and RNA replication are required for AUF1 restriction of enterovirus infections in human cells. mBio 9:e01669-18. 10.1128/mBio.01669-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01669-18</ArticleId><ArticleId IdType="pmc">PMC6123441</ArticleId><ArticleId IdType="pubmed">30181254</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozovics JM, Chase AJ, Cathcart AL, Chou W, Gershon PD, Palusa S, Wilusz J, Semler BL. 2012. Picornavirus modification of a host mRNA decay protein. mBio 3:e00431-12. 10.1128/mBio.00431-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00431-12</ArticleId><ArticleId IdType="pmc">PMC3487778</ArticleId><ArticleId IdType="pubmed">23131833</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue YC, Ng CS, Xiang P, Liu H, Zhang K, Mohamud Y, Luo H. 2020. Dysregulation of RNA-binding proteins in amyotrophic lateral sclerosis. Front Mol Neurosci 13:78. 10.3389/fnmol.2020.00078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00078</ArticleId><ArticleId IdType="pmc">PMC7273501</ArticleId><ArticleId IdType="pubmed">32547363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddique T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH, Jr.. 2009. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205&#x2013;1208. 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Ganesalingam J, Williams KL, Tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE. 2009. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208&#x2013;1211. 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama RR, Ward CL, Bosco DA. 2014. Functions of FUS/TLS from DNA repair to stress response: implications for ALS. ASN Neuro 6:175909141454447. 10.1177/1759091414544472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759091414544472</ArticleId><ArticleId IdType="pmc">PMC4189536</ArticleId><ArticleId IdType="pubmed">25289647</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson MF, Baltimore D. 1968. Polypeptide cleavages in the formation of poliovirus proteins. Proc Natl Acad Sci U S A 61:77&#x2013;84. 10.1073/pnas.61.1.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.61.1.77</ArticleId><ArticleId IdType="pmc">PMC285907</ArticleId><ArticleId IdType="pubmed">4301595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson PJ, Hossain AR, Qiu Y, Zhang HM, Zhao G, Li C, Lin V, Sulaimon S, Vlok M, Fung G, Chen VH, Jan E, McManus BM, Granville DJ, Yang D. 2019. Cleavage and sub-cellular redistribution of nuclear pore protein 98 by coxsackievirus B3 protease 2A impairs cardioprotection. Front Cell Infect Microbiol 9:265. 10.3389/fcimb.2019.00265.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00265</ArticleId><ArticleId IdType="pmc">PMC6667557</ArticleId><ArticleId IdType="pubmed">31396490</ArticleId></ArticleIdList></Reference><Reference><Citation>Park N, Katikaneni P, Skern T, Gustin KE. 2008. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J Virol 82:1647&#x2013;1655. 10.1128/JVI.01670-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01670-07</ArticleId><ArticleId IdType="pmc">PMC2258732</ArticleId><ArticleId IdType="pubmed">18045934</ArticleId></ArticleIdList></Reference><Reference><Citation>Carthy CM, Granville DJ, Watson KA, Anderson DR, Wilson JE, Yang D, Hunt DW, McManus BM. 1998. Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol 72:7669&#x2013;7675. 10.1128/JVI.72.9.7669-7675.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.9.7669-7675.1998</ArticleId><ArticleId IdType="pmc">PMC110038</ArticleId><ArticleId IdType="pubmed">9696873</ArticleId></ArticleIdList></Reference><Reference><Citation>Coady TH, Manley JL. 2015. ALS mutations in TLS/FUS disrupt target gene expression. Genes Dev 29:1696&#x2013;1706. 10.1101/gad.267286.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.267286.115</ArticleId><ArticleId IdType="pmc">PMC4561479</ArticleId><ArticleId IdType="pubmed">26251528</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M, Chen J, Kuang L, Jin H, Kasarskis EJ, Zhu H. 2018. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc Natl Acad Sci U S A 115:E11904&#x2013;E11913. 10.1073/pnas.1810413115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810413115</ArticleId><ArticleId IdType="pmc">PMC6304956</ArticleId><ArticleId IdType="pubmed">30455313</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloc A, Rai DK, Rieder E. 2018. The roles of picornavirus untranslated regions in infection and innate immunity. Front Microbiol 9:485. 10.3389/fmicb.2018.00485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00485</ArticleId><ArticleId IdType="pmc">PMC5870040</ArticleId><ArticleId IdType="pubmed">29616004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Qiu Y, Zhang HM, Hanson P, Ye X, Zhao G, Xie R, Tong L, Yang D. 2017. Heat shock protein 70 promotes coxsackievirus B3 translation initiation and elongation via Akt-mTORC1 pathway depending on activation of p70S6K and Cdc2. Cell Microbiol 19:12725. 10.1111/cmi.12725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12725</ArticleId><ArticleId IdType="pubmed">28095607</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus SE, Diamond DC, Emini EA, Wimmer E. 1986. Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol 57:638&#x2013;646. 10.1128/JVI.57.2.638-646.1986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.57.2.638-646.1986</ArticleId><ArticleId IdType="pmc">PMC252779</ArticleId><ArticleId IdType="pubmed">3003395</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat Rev Immunol 8:559&#x2013;568. 10.1038/nri2314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2314</ArticleId><ArticleId IdType="pmc">PMC2522268</ArticleId><ArticleId IdType="pubmed">18575461</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng CS, Jogi M, Yoo J-S, Onomoto K, Koike S, Iwasaki T, Yoneyama M, Kato H, Fujita T. 2013. Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses. J Virol 87:9511&#x2013;9522. 10.1128/JVI.03248-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03248-12</ArticleId><ArticleId IdType="pmc">PMC3754122</ArticleId><ArticleId IdType="pubmed">23785203</ArticleId></ArticleIdList></Reference><Reference><Citation>Onomoto K, Jogi M, Yoo J-S, Narita R, Morimoto S, Takemura A, Sambhara S, Kawaguchi A, Osari S, Nagata K, Matsumiya T, Namiki H, Yoneyama M, Fujita T. 2012. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One 7:e43031. 10.1371/journal.pone.0043031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043031</ArticleId><ArticleId IdType="pmc">PMC3418241</ArticleId><ArticleId IdType="pubmed">22912779</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly N, Gorman AM, Gupta S, Samali A. 2013. The eIF2alpha kinases: their structures and functions. Cell Mol Life Sci 70:3493&#x2013;3511. 10.1007/s00018-012-1252-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-012-1252-6</ArticleId><ArticleId IdType="pmc">PMC11113696</ArticleId><ArticleId IdType="pubmed">23354059</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y, Qu J, Xue YC, Liu H, Deng H, Luo H. 2019. CALCOCO2/NDP52and SQSTM1/p62 differentially regulate coxsackievirus B3 propagation. Cell Death Differ 26:1062&#x2013;1076. 10.1038/s41418-018-0185-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0185-5</ArticleId><ArticleId IdType="pmc">PMC6748094</ArticleId><ArticleId IdType="pubmed">30154446</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y, Shi J, Qu J, Poon T, Xue YC, Deng H, Zhang J, Luo H. 2018. Enteroviral infection inhibits autophagic flux via disruption of the SNARE complex to enhance viral replication. Cell Rep 22:3292&#x2013;3303. 10.1016/j.celrep.2018.02.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.02.090</ArticleId><ArticleId IdType="pubmed">29562184</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenas A, Kuang L, Zhang J, Kingren MS, Zhu H. 2020. FUS regulates autophagy by mediating the transcription of genes critical to the autophagosome formation. J Neurochem 10.1111/jnc.15281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15281</ArticleId><ArticleId IdType="pmc">PMC8364620</ArticleId><ArticleId IdType="pubmed">33354770</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y, Luo H. 2019. The intertwined life cycles of enterovirus and autophagy. Virulence 10:470&#x2013;480. 10.1080/21505594.2018.1551010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2018.1551010</ArticleId><ArticleId IdType="pmc">PMC6550542</ArticleId><ArticleId IdType="pubmed">30475087</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang L, Kamelgarn M, Arenas A, Gal J, Taylor D, Gong W, Brown M, St Clair D, Kasarskis EJ, Zhu H. 2017. Clinical and experimental studies of a novel P525R FUS mutation in amyotrophic lateral sclerosis. Neurol Genet 3:e172. 10.1212/NXG.0000000000000172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000172</ArticleId><ArticleId IdType="pmc">PMC5546284</ArticleId><ArticleId IdType="pubmed">28812062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC, Clutario KM, Ling SC, Liang TY, Mazur C, Wancewicz E, Kim AS, Watt A, Freier S, Hicks GG, Donohue JP, Shiue L, Bennett CF, Ravits J, Cleveland DW, Yeo GW. 2012. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci 15:1488&#x2013;1497. 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack GE, Luisier R, Taha DM, Neeves J, Modic M, Mitchell JS, Meyer I, Greensmith L, Newcombe J, Ule J, Luscombe NM, Patani R. 2019. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain 142:2572&#x2013;2580. 10.1093/brain/awz217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz217</ArticleId><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova TA, An H, Skelt L, Tregoning JS, Humphreys IR, Buchman VL. 2019. Antiviral immune response as a trigger of FUS proteinopathy in amyotrophic lateral sclerosis. Cell Rep 29:4496&#x2013;4508.E4. 10.1016/j.celrep.2019.11.094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.11.094</ArticleId><ArticleId IdType="pmc">PMC6941233</ArticleId><ArticleId IdType="pubmed">31875556</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber S, Mechtersheimer J, Nasif S, Benitez JA, Colombo M, Domanski M, Jutzi D, Hedlund E, Ruepp MD. 2018. CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells. Mol Biol Cell 29:75&#x2013;83. 10.1091/mbc.E17-05-0288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E17-05-0288</ArticleId><ArticleId IdType="pmc">PMC5909934</ArticleId><ArticleId IdType="pubmed">29167381</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham HD, Dahrouge S, Cashman NR. 1993. Evaluation of the spinal cord neuron X neuroblastoma hybrid cell line NSC-34 as a model for neurotoxicity testing. Neurotoxicology 14:387&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">7909362</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris KG, Morosky SA, Drummond CG, Patel M, Kim C, Stolz DB, Bergelson JM, Cherry S, Coyne CB. 2015. RIP3 regulates autophagy and promotes coxsackievirus B3 infection of intestinal epithelial cells. Cell Host Microbe 18:221&#x2013;232. 10.1016/j.chom.2015.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2015.07.007</ArticleId><ArticleId IdType="pmc">PMC4562276</ArticleId><ArticleId IdType="pubmed">26269957</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung G, Ng CS, Zhang J, Shi J, Wong J, Piesik P, Han L, Chu F, Jagdeo J, Jan E, Fujita T, Luo H. 2013. Production of a dominant-negative fragment dueto G3BP1 cleavage contributes to the disruption of mitochondria-associated protective stress granules during CVB3 infection. PLoS One 8:e79546. 10.1371/journal.pone.0079546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079546</ArticleId><ArticleId IdType="pmc">PMC3832613</ArticleId><ArticleId IdType="pubmed">24260247</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, Grad LI, Yousefi M, Wang J, Mackenzie IR, Cashman NR. 2012. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis. PLoS One 7:e35050. 10.1371/journal.pone.0035050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035050</ArticleId><ArticleId IdType="pmc">PMC3320864</ArticleId><ArticleId IdType="pubmed">22493728</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrocola AS, Kim SH, Trinh AT, Rodenkirch LA, Tibbetts RS. 2013. The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage. J Biol Chem 288:24731&#x2013;24741. 10.1074/jbc.M113.497974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.497974</ArticleId><ArticleId IdType="pmc">PMC3750169</ArticleId><ArticleId IdType="pubmed">23833192</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagdeo JM, Dufour A, Klein T, Solis N, Kleifeld O, Kizhakkedathu J, Luo H, Overall CM, Jan E. 2018. N-terminomics TAILS identifies host cell substrates of poliovirus and coxsackievirus B3 3C proteinases that modulatevirus infection. J Virol 92:e02211-17. 10.1128/JVI.02211-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02211-17</ArticleId><ArticleId IdType="pmc">PMC5874412</ArticleId><ArticleId IdType="pubmed">29437971</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Epidemiol 27:493&#x2013;497. 10.1093/oxfordjournals.aje.a118408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M. 1985. Selection of nonfastidious adenovirus species in 293 cells inoculated with stool specimens containing adenovirus 40. J Clin Microbiol 22:205&#x2013;209. 10.1128/JCM.22.2.205-209.1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.22.2.205-209.1985</ArticleId><ArticleId IdType="pmc">PMC268359</ArticleId><ArticleId IdType="pubmed">2993350</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>